Copanlisib (Aliqopa, BAY80-6946)
17067
Phase 3 small_molecule completed
Quick answer
Copanlisib (Aliqopa, BAY80-6946) for Lymphoma,Non-Hodgkin is a Phase 3 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Lymphoma,Non-Hodgkin
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed